arrow
M

Michael G. Hanna

UCL Queen Square Institute of Neurology
H-index:95
Citation Count:4.2万
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

Late-Onset Tay–Sachs Disease With SMALED-Like Muscle MRI Pattern Despite a Distinct Clinical Phenotype

迟发性Tay–Sachs病具有SMALED样肌肉MRI模式,尽管临床表型独特

2026-09-110
OAAI
COXFA4L2 upregulation preserves residual cytochrome c oxidase activity in COXFA4-related Leigh-like encephalopathy

COXFA4L2上调在COXFA4相关 Leigh样脑病中维持残余细胞色素c氧化酶活性

2026-05-300
OA
Mavodelpar in patients with primary mitochondrial myopathy: a phase 1 trial

Mavodelpar在原发性线粒体肌病患者中的应用:一项1期临床试验

2026-05-180
OAAI
Phenotypic characterization of dominantly inherited distal nebulin myopathy

显性遗传性远端 Nebulin 肌营养不良的表型特征

2026-05-010
OAAI
Intersection of Spinal Muscular Atrophy and Progressive Myoclonic Epilepsy Syndrome: ASAH1 Gene

脊髓性肌萎缩症与进行性肌阵挛癫痫综合征的交集:ASAH1基因

2026-05-010
PRE
Biallelic variants in COX18 cause a mitochondrial disorder primarily manifesting as peripheral neuropathy

COX18基因的双等位基因变异会导致一种主要表现为周围神经病的线粒体疾病。

BRAIN
IF11.7
2025-12-010
OA
Expression of genetic peripheral neuropathies in South African Children

南非儿童中遗传性周围神经病的表达

2025-11-220
OAAI
Long term safety and efficacy of lamotrigine in patients with non-dystrophic myotonia, a single-centre prospective study.

长期安全性及疗效:拉莫三嗪在非强直性肌强直患者中的单中心前瞻性研究。

2025-09-240
OAAI
Generative Artificial Intelligence in Pathology and Medicine: A Deeper Dive
2025-04-011
OAAI
Introducing an Essential 7-Part Artificial Intelligence Review Series: A Guided Journey Into the Future of Pathology and Medicine

介绍一个重要的7部分人工智能评论系列: 引导病理学和医学的未来之旅

2025-03-010
PRE
MRC Centre for Neuromuscular Diseases Biobank London: its role in the advancement of rare and neuromuscular diseases research

MRC Centre for Neuromuscular Diseases生物样本库,伦敦:其在罕见病和神经肌肉疾病研究进展中的作用

2025-03-010
OAAI
Biallelic variants in RYR1 and STAC3 are predominant causes of King-Denborough Syndrome in an African cohort
2025-02-181
OAAI
Twelve-month change in quantitative MRI calf muscle fat fraction in CMT1A predicts clinical change over 4 years

CMT1A中定量MRI小腿肌肉脂肪分数的12个月变化可预测4年内的临床变化

2025-02-170
OA
Optimizing rare disorder trials: a phase 1a/1b randomized study of KL1333 in adults with mitochondrial disease
BRAIN
IF11.7
2024-12-090
PRE
Overcoming genetic neuromuscular diagnostic pitfalls in a middle-income country
2024-11-140
OAAI
Increase in serum TTR levels observed with acoramidis treatment in patients with transthyretin amyloid cardiomyopathy (ATTR-CM): insights from ATTRibute-CM and its open-label extension
2024-10-280
PRE
Tafamidis treatment for transthyretin amyloid cardiomyopathy: results from an open-label, early-access, long-term study extension in an all-comers population
2024-10-280
PRE
Beyond the cochlea: exploring the multifaceted nature of hearing loss in primary mitochondrial diseases

超越耳蜗: 探索原发性线粒体疾病中听力损失的多面性

2024-10-240
OAAI
Mutant PTPMT1 disrupts cardiolipin metabolism and mitochondrial bioenergetics leading to a neurodevelopmental syndrome
2024-09-010
PRE